U.S. Artificial Intelligence In Drug Discovery Market Size & Outlook
U.S. artificial intelligence in drug discovery market, 2018-2030 (US$M)
Related Markets
U.S. artificial intelligence in drug discovery market highlights
- The U.S. artificial intelligence in drug discovery market generated a revenue of USD 776.7 million in 2023 and is expected to reach USD 4,488.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 28.5% from 2024 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic space in 2023.
- Infectious Disease is the most lucrative therapeutic space segment registering the fastest growth during the forecast period.
Artificial intelligence in drug discovery market data book summary
| Market revenue in 2023 | USD 776.7 million |
| Market revenue in 2030 | USD 4,488.5 million |
| Growth rate | 28.5% (CAGR from 2024 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Infectious Disease |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
Other key industry trends
- In terms of revenue, U.S. accounted for 52.6% of the global artificial intelligence in drug discovery market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. artificial intelligence in drug discovery market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 473.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence in Drug Discovery Market Scope
Artificial Intelligence in Drug Discovery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. artificial intelligence in drug discovery market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.44% in 2023. Horizon Databook has segmented the U.S. artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2018 to 2030.
Availability of developed infrastructure to facilitate the adoption of AI, coupled with the local presence of major players operating, is expected to contribute to market growth. In addition, growing awareness about AI and increasing number of manufacturers adopting it to lower costs of drug discovery is expected to further support market growth in the U.S.
In August 2017, BERG—a biopharmaceutical company—entered into a research collaboration with AstraZeneca to identify and evaluate novel therapeutics & targets for the treatment of Parkinson’s disease using its AI platform, BERG Interrogative Biology.
This research collaboration provided AstraZeneca with new and innovative ways of drug discovery approaches by using BERG’s AI platform. In addition, this collaboration would help BERG in recognizing new therapeutic targets that can potentially benefit patients suffering from neurological disorders.
Reasons to subscribe to U.S. artificial intelligence in drug discovery market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. artificial intelligence in drug discovery market databook
-
Our clientele includes a mix of artificial intelligence in drug discovery market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into U.S. artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. artificial intelligence in drug discovery market size, by therapeutic space, 2018-2030 (US$M)
U.S. Artificial Intelligence in Drug Discovery Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
